Celsion Corp
NASDAQ:CLSN 3:59:47 PM EDT
| Market Cap (Intraday) | 90.45M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.11 |
| 50-Day MA | $1.55 |
| 200-Day MA | $1.11 |
Celsion Corp Stock, NASDAQ:CLSN
997 Lenox Drive, Suite 100, Lawrenceville, New Jersey 08648
United States of America
Phone: +1.609.896.9100
Number of Employees: 27
Description
Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.